Impact of the TGF-β1 isoform on p53 signalling in ovarian cancer cell lines in response to cisplatin

被引：0
|
作者：
Baribeau, Sebastien [1 ]
Chaudhry, Parvesh [1 ]
Asselin, Eric [1 ]
机构：
[1] Univ Quebec Trois Rivieres, Trois Rivieres, PQ GA9 5H7, Canada
来源：
CANCER RESEARCH | 2012年 / 72卷
关键词：
D O I：
10.1158/1538-7445.AM2012-4901
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4901
引用
收藏
页数：2
相关论文
共 50 条
  • [31] TGF-β1 Suppresses p53 Expression and Induces Resistance to Apoptosis in Colorectal Cancer Cells Lacking Functional Type II TGF-β Receptor
    Tsujii, Yoshiki
    Hayashi, Yoshito
    Tsujii, Masahiko
    Yoshii, Shunsuke
    Nagai, Kengo
    Fujinaga, Tetsuji
    Maekawa, Akira
    Inoue, Takuya
    Watabe, Kenji
    Iijima, Hideki
    Takehara, Tetsuo
    GASTROENTEROLOGY, 2015, 148 (04) : S954 - S954
  • [32] p53 response of cancer associated fibroblasts (CAFs) to cisplatin is closely correlated with the p53 response of tumor cells in lung cancer tissue cultures
    Schmid, Jens O.
    Dong, Meng
    Haubeiss, Silke
    Friedel, Godehard
    Oren, Moshe
    Muerdter, Thomas E.
    Aulitzky, Walter E.
    van der Kuip, Heiko
    CANCER RESEARCH, 2012, 72
  • [33] Inhibition of p53 function diminishes androgen receptor-mediated signalling inprostate cancer cell lines
    不详
    EUROPEAN UROLOGY SUPPLEMENTS, 2005, 4 (03) : 25 - 25
  • [34] Role of p53 in human ovarian cancer tumour xenografts curable with cisplatin.
    Pestell, KE
    Medlow, CJ
    Jones, M
    Valenti, M
    Brunton, L
    Kelland, LR
    Walton, MI
    BRITISH JOURNAL OF CANCER, 1998, 78 : 28 - 28
  • [35] Cancer Cells Cue the p53 Response of Cancer-Associated Fibroblasts to Cisplatin
    Schmid, Jens O.
    Dong, Meng
    Haubeiss, Silke
    Friedel, Godehard
    Bode, Sabine
    Grabner, Andreas
    Ott, German
    Muerdter, Thomas E.
    Oren, Moshe
    Aulitzky, Walter E.
    van der Kuip, Heiko
    CANCER RESEARCH, 2012, 72 (22) : 5824 - 5832
  • [36] p53 overexpression is associated with cytoreduction and response to chemotherapy in ovarian cancer
    G Ferrandina
    A Fagotti
    M G Salerno
    P G Natali
    M Mottolese
    F Maneschi
    A De Pasqua
    P Benedetti-Panici
    S Mancuso
    G Scambia
    British Journal of Cancer, 1999, 81 : 733 - 740
  • [37] p53 overexpression is associated with cytoreduction and response to chemotherapy in ovarian cancer
    Ferrandina, G
    Fagotti, A
    Salerno, MG
    Natali, PG
    Mottolese, M
    Maneschi, F
    De Pasqua, A
    Benedetti-Panici, P
    Mancuso, S
    Scambia, G
    BRITISH JOURNAL OF CANCER, 1999, 81 (04) : 733 - 740
  • [38] Humoral p53 antibody response is a prognostic parameter in ovarian cancer
    Mayerhofer, K
    Tempfer, C
    Kucera, E
    Hefler, L
    Zeisler, H
    Kainz, C
    Zeillinger, R
    Sliutz, G
    ANTICANCER RESEARCH, 1999, 19 (1B) : 875 - 878
  • [39] TGF-β1/SMAD SIGNALING PATHWAY MEDIATES p53-DEPENDENT APOPTOSIS IN HEPATOMA CELL LINES
    Chun-lei Wang 1*
    ChineseMedicalSciencesJournal, 2006, (01) : 33 - 35
  • [40] The N-Terminally Truncated p53 Isoform Δ40p53 Influences Prognosis in Mucinous Ovarian Cancer
    Hofstetter, Gerda
    Berger, Astrid
    Berger, Regina
    Zoric, Arijana
    Braicu, Elena I.
    Reimer, Daniel
    Fiegl, Heidi
    Marth, Christian
    Zeimet, Alain G.
    Ulmer, Hanno
    Moll, Ute
    Zeillinger, Robert
    Concin, Nicole
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2012, 22 (03) : 372 - 379
12345